Please sign in to follow a disease.
Exudative vitreoretinopathy
MONDO:0019516Familial exudative vitreoretinopathy (FEVR) is a rare hereditary vitreoretinal disorder characterized by abnormal or incomplete vascularization of the peripheral retina leading to variable clinical manifestations ranging from no effects to minor anomalies, or even retinal detachment with blindness.
Also known as: Criswick-Schepens syndrome, FEVR, familial exudative vitreoretinopathy, exudative vitreoretinopathy, familial
53 clinical trials for this condition and its sub-types, 1 tagged with Exudative vitreoretinopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Exudative vitreoretinopathy
-
FZD4-related exudative vitreoretinopathy 0 trials · 33 incl. sub-types
2 sub-types
- Retinopathy of prematurity 33 trials
- Exudative vitreoretinopathy 1 0 trials
-
Dyneinopathy 0 trials · 1 incl. sub-types
2 sub-types
-
2 sub-types
- Exudative vitreoretinopathy 4 0 trials
- Osteoporosis-pseudoglioma syndrome 0 trials
-
1 sub-type
- Exudative vitreoretinopathy 5 0 trials
-
Exudative vitreoretinopathy 3 0 trials
-
Exudative vitreoretinopathy 6 0 trials
-
Exudative vitreoretinopathy 7 0 trials
-
Exudative vitreoretinopathy 8 0 trials
-
Tiny doses of avastin tested against laser for preemie eye disease
Disease control Stopped earlyThis study tested a low dose of the drug bevacizumab (Avastin) against standard laser treatment for retinopathy of prematurity, an eye disease that can blind premature infants. Sixteen babies with severe disease were enrolled. The goal was to see if the drug could control the dis…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
VR headsets tested as a possible treatment for blindness
Disease control Stopped earlyThis study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…
Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New eye scanner software could sharpen diagnosis of macular degeneration
Diagnosis Stopped earlyThis study tested a new software called AngioScan, used with an already-approved eye camera, to see if it can take better pictures of the back of the eye. Researchers looked at 150 patients with retinal problems like macular degeneration. The goal was to find out if the software …
Sponsor: University of California, Los Angeles • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC